Mario Gabelli Moderna, Inc. Transaction History

Gamco Investors, Inc. Et Al

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $379,380 - $705,150	-3,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $677,460 - $1.11 Million	-3,000 Reduced 50.0%	3,000 $762,000
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $129,910 - $234,980	1,000 Added 20.0%	6,000 $1.41 Million
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $545,900 - $929,900	5,000 New	5,000 $655,000
Q4 2020 Feb 05, 2021	SELL	$65.74 - $169.86 $337,903 - $873,080	-5,140 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$29.67 - $80.0 $152,503 - $411,200	5,140 New	5,140 $330,000

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.